Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Window of opportunity study of enobosarm in ER+/AR+ early breast cancer
2016-000543-13Phase 2Unknown
- Sponsor
- University of Liverpool
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of enobosarm in breast cancer, sponsored by University of Liverpool. Primary endpoint: Change in Ki67 proliferation index. Status: unknown.
02
Drugs
enobosarm
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2016-000543-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000543-13.